Important gender differences in mood disorders result in a greater susceptibility for women. Accumulating evidence suggests a reciprocal modulation between the 5-hydroxytryptamine (5-HT) system and neuroactive steroids. Previous data from our laboratory have shown that during pregnancy, the firing activity of 5-HT neurons increases in parallel with progesterone levels. This study was undertaken to evaluate the putative modulation of the 5-HT neuronal firing activity by different neurosteroids. Female rats received i.c.v. for 7 days a dose of 50 µg/kg per day of one of the following steroids: progesterone, pregnenolone, 5 -pregnane-3,20-dione (5 -DHP), 3 ,, 5 -pregnane-3 -ol,20-one and dehydroepiandrosterone (DHEA). 5 -DHP and DHEA were also administered for 14 and 21 days (50 µg/ kg per day, i.c.v.) as well as concomitantly with the selective sigma 1 ( 1 ) receptor antagonist NE-100. In vivo, extracellular unitary recording of 5-HT neurons performed in the dorsal raphe nucleus of these rats revealed that DHEA, 5 -DHP and 3 ,5 -THP significantly increased the firing activity of the 5-HT neurons. Interestingly, 5 -DHP and DHEA showed different timeframes for their effects with 5 -DHP having its greatest effect after 7 days to return to control values after 21 days, whereas DHEA demonstrated a sustained effect over the 21 day period. NE-100 prevented the effect of DHEA but not of 5 -DHP, thus indicating that its 1 receptors mediate the effect of DHEA but not that of 5 -DHP. In conclusion, our results offer a cellular basis for potential antidepressant effects of neurosteroids, which may prove important particularly for women with affective disorders.
Introduction
There are important gender differences in susceptibility for mood disorders. Women experience depressive episodes earlier in life, more frequently, more recurrently and more persistently than men (Weissman & Klerman 1977 , 1985 , Maes et al. 1986 , Parry 1989 , Hamilton 1993 , Kessler et al. 1994 , Weissman et al. 1996 , Kornstein 1997 , Joffe & Cohen 1998 . The mechanisms underlying these gender differences are not understood. It has been suggested that the frequent hormonal variations experienced by women might contribute to their vulnerability to depression (Endicott 1993 , Pajer 1995 , Kornstein 1997 , Joffe & Cohen 1998 . Although the etiology of major depression remains unclear, the enhancement of serotonergic (5-hydroxytryptamine (5-HT)) neurotransmission observed with antidepressant treatments suggests the implication of the 5-HT system in the biology of depression (Blier & de Montigny 1999 , Racagni & Brunello 1999 .
Ovarian steroids are known to affect brain areas not directly related to reproductive functions, such as the dorsal raphe nuclei (DRN) (McEwen et al. 1998) . This nucleus being a region rich in 5-HT neuron cell bodies, ovarian steroids may have a functional impact on the 5-HT system. Numerous studies, performed in females, indicate that ovarian steroids modulate the expression of several genes of the 5-HT system (e.g. tryptophan hydroxylase, vesicular monoamine transporter, serotonin reuptake transporter and different 5-HT receptors) (see review by Bethea et al. 1999) .
Moreover, there is accumulating evidence suggesting that depressive states may be associated with a decrease in 5 -pregnane-3 -ol,20-one (allopregnanolone, 3 ,5 -THP) levels. For instance, in a mouse model of depression, long-term social isolation decreases the cortical levels of 3 ,5 -THP and 5 -pregnane-3,20-dione (5 -DHP) (Dong et al. 2001) . Also, the levels of 3 , were shown to be significantly lower in the cerebrospinal fluid (CSF) and plasma of depressed patients as compared with controls (Romeo et al. 1998 , Uzunova et al. 1998 . Conversely, selective serotonin reuptake inhibitors (SSRIs) have been shown to increase the cerebral content of some neuroactive steroids in both rats and humans (Uzunov et al. 1996 , Griffin & Mellon 1999 , Serra et al. 2001 . Furthermore, successful antidepressant treatments not only regularize the levels of neuroactive steroids, but the extent of the increase in CSF contents of 3 ,5 -THP and 3 ,5 -THP is also proportional to the mood improvement (Romeo et al. 1998 , Uzunova et al. 1998 .
Using an in vivo electrophysiological paradigm of extracellular recordings, we have previously shown that the spontaneous firing activity of DRN 5-HT neurons is significantly higher in male than in female rats, while ovariectomy (OVX) did not significantly modify the female 5-HT neuronal basal firing rate. Interestingly, during pregnancy, the spontaneous firing rate increased gradually to peak at the 17th day of pregnancy and then declined before parturition, thus following circulating levels of progesterone (but not of estrogen) .
Furthermore, we showed that, during pregnancy, 5-HT 1A autoreceptors were partly desensitized and that 5-HT neurons were probably under a much lower -aminobutyric acid (GABA)ergic tonic inhibition as compared with that of freely cycling females (FC) . Both of these functional modifications are consistent with the enhanced firing activity of 5-HT neurons observed during pregnancy. They also provide possible mechanisms by which hormonal fluctuations can modulate 5-HT neuron function and influence women's vulnerability to mood disorders.
Taken together, the literature and our previous data suggest a reciprocal modulation between the 5-HT system and neuroactive steroids. Therefore, the goal of the present studies was to assess a possible modulation of 5-HT neuron firing activity by progesterone and its metabolites (see Fig. 1 ).
Materials and Methods

Animals
Sprague-Dawley rats (Charles-River, St-Constant, Québec, Canada) weighing between 250 and 325 g were kept under standard laboratory conditions (12 h light:12 h darkness cycle with free access to food and water). FC and OVX females were used for the experiments. Ethical committee approval was obtained from the McGill University Animal Ethical Care Committee and all their rules and regulations were followed. The suffering of animals as well as the number used was kept at a minimum.
Treatment with inhibitors of progesterone synthesis and metabolism
OVX females operated at their 8th week of life were used for treatments with trilostane and finasteride. Trilostane treatments began at the 9th week of life. Trilostane suspended in sesame oil was administered by daily s.c. injections of 25 mg/kg for 14 days. Finasteride treatments began at the 10th week of life. Finasteride suspended in 1·5% methylcellulose was administered for 5 days by daily gavage of 20 mg/kg. These doses of finasteride and trilostane have previously been shown to efficiently inhibit the 5 -reductase and 3 -hydroxysteroid dehydrogenase (3 -HSOD) enzymatic activities respectively (Potts et al. 1978 , Young et al. 1994 , Phan et al. 1999 , Micevych et al. 2003 . Experiments were carried out on the day following the last administration of either drug.
Treatments with steroids
All steroids were dissolved in 3% (v/v) ethanol/distilled water and administered i.c.v. continuously by mean of an s.c. osmotic minipump connected to a cannula (ALZA, Palo Alto, CA, USA), which was implanted in the left lateral ventricle of the rat brain. The surgery was performed as described by the manufacturer (ALZA) and under chloral hydrate anesthesia. Each steroid was administered at a dose of 50 µg/kg per day. NE-100 (N,N-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)-ethylamine), a sigma 1 ( 1 ) receptor antagonist, was dissolved in distilled water and administered s.c. by an osmotic minipump for a daily dose of 10 mg/kg. FC received one of the following treatments: 7, 14 or 21 days with either 5 -pregnane-3,20-dione (5 -DHP) or dehydroepiandrosterone (DHEA); 7 days with either progesterone, pregnenolone (PREG), 3 ,5 -THP, 5 -pregnane-3 -ol,20-one (3 ,5 -THP), 5 -DHP, 3 ,5 -THP or 5 -pregnane-3 -ol,20-one (3 ,5 -THP); 7 days with either 5 -DHP or DHEA concomitantly with NE-100. A first control for the surgical procedure was obtained with i.c.v. administration of saline for 7 days. A second series of controls received 3% ethanol, i.c.v., for 7 days. Experiments were carried out the day following the last day of administration and after removal of the cannulae. Following experiments, every brain was removed, frozen at -80 C and sliced using a microtome to confirm the position of both the cannula and the recording electrode.
Electrophysiological experiments
All rats were anesthetized by an i.p. injection of chloral hydrate (400 mg/kg) and additional doses of 100 mg/kg were administered when needed. Rats were immobilized in a stereotaxic apparatus and their body temperature was maintained at approximately 37 C throughout the experiment by a thermistor-controlled heating pad.
Extracellular unitary recording of serotonergic neurons were conducted with single-barreled glass micropipettes pulled in a conventional manner, filled with a 1 M NaCl solution and of final impedance ranging between 2 and 6 M . A 4 mm diameter hole was drilled in the skull of each rat at the appropriate location (about 1 mm anterior of lambda and centered with respect to the midline). DRN 5-HT neurons unit activity was recorded by lowering the micropipette along descents covering the nucleus from 300 µm to about 1500 µm anterior of lambda. Spontaneously active DRN 5-HT neurons were identified according to the criteria of Aghajanian et al. (1978) : a slow and regular rhythmical firing rate and positive action potentials of long duration.
For each group of rats, the basal firing rate of 5-HT neurons was calculated by averaging the firing rate of each neuron measured. This was achieved by recording, for at least 60 s, each 5-HT neuron encountered in complete descents in the DRN of three to six rats.
Statistics
Statistical analysis were performed with the software SigmaStat for Windows Version 2·0 (Jandel Corporation, San Rafael, CA, USA). Average values are given as the means S.E.M. One-way ANOVA, with alpha=0·05, followed by a post-hoc analysis using Tukey's method of comparison vs control was used for evaluating statistical significance. Results (F) of statistical analysis are expressed in terms of degrees of freedom between groups compared and number of groups compared. Significance was considered for P,0·05.
Drugs
Trilostane was obtained from Sanofi Research Division (Malvern, PA, USA), NE-100 was kindly provided by Taisho Pharmaceutical Co. Ltd (Tokyo, Japan) and finasteride was prepared from 5 mg commercial pills of Proscar (Merck Frosst, Kirkland, Québec, Canada). Steroids used were: progesterone, PREG, 5 -DHP, 3 ,5 -THP, 3 ,5 -THP, 5 -DHP, 3 ,5 -THP, 3 ,5 -THP (Steraloid) and DHEA (Sigma, Newport, RI, USA).
Results
Two types of controls were separately carried out in order to assess the potential effect of the surgical procedure and of the vehicle. Since the surgical control (saline, i.c.v.) was very similar to FC (1·01 0·07 Hz, n=70, and 1·02 0·07 Hz, n=72 respectively (data not shown)), the vehicle control was used for comparison with the subsequent treatments. Progesterone, administered i.c.v. for 7 days to FC did not significantly modify the firing activity of 5-HT neurons (1·21 0·07 Hz, n=95 vs 1·18 0·10 Hz, n=52 (F(1,2)=0·09, n.s.)) (Fig. 2) .
Since in a previous series of experiments, OVX did not decrease the basal firing activity of 5-HT neurons , we decided to investigate if the cerebral de novo synthesis of progesterone was sufficient to maintain the basal 5-HT neuron activity. Thus, to prevent local progesterone synthesis, OVX rats were treated with trilostane (an inhibitor of the 3 -hydroxysteroid dehydrogenase, the enzyme responsible for converting PREG into progesterone, see Fig. 1 ). As reported before, the firing activity of 5-HT neurons was not significantly modified following OVX (as compared with FC (F(1,2)= 1·19 0·12 Hz, n=43 vs 1·02 0·07 Hz, n=72, n.s.), Fig. 3A) . Following the treatment with trilostane (25 mg/kg per day for 14 days), the firing activity of 5-HT neurons was increased by less than 10%, which was not statistically significant as compared with OVX (1·29 0·11 Hz, n=44 and 1·19 0·12 Hz, n=43 respectively (F(1,2)= 0·37, n.s.), Fig. 3B ).
As another way to assess the capacity of the cerebral de novo synthesis of progesterone to influence the basal firing rate of DRN 5-HT neurons, OVX were treated with finasteride (20 mg/kg per day for 5 days), a selective blocker of the 5 -reductase (the enzyme metabolizing progesterone into 5 -DHP, see Fig. 1 ). This was done to prevent the catabolism of progesterone and, therefore, to increase its cerebral levels. Increasing progesterone levels with finasteride did not significantly increase 5-HT neuron firing activity as compared with OVX (1·34 0·08 Hz, n=42 and 1·19 0·12 Hz, n=43 respectively (F(1,2)= 1·00, n.s.), Fig. 3B ).
Since progesterone does not seem to affect the firing activity of 5-HT neurons, the effects of its precursor and of some of its metabolites were investigated. As was the case with progesterone, a 7 day treatment with PREG led to a non-significant increase in 5-HT neuronal firing rate (1·52 0·17 Hz, n=55 vs 1·19 0·13 Hz, n=41 (F(1,2)=2·07, n.s.), Fig. 4) .
In parallel to progesterone, DHEA is also synthesized from PREG (Fig. 1) . The DHEA treatments led to an increase in firing activity, which persisted over time (Fig. 5) . After 7 days, the mean firing frequency of 5-HT neurons was increased from 0·96 0·08 Hz, n=52, to 1·48 0·11 Hz, n=78 (F(5,6)=7·92, P,0·001, Tukey's test, q=4·8, P,0·01), after 14 days, it was increased from 1·10 0·09 Hz, n=54 to 1·66 0·11 Hz, n=68 (F(5,6)=7·92, P,0·001, Tukey's test, q=5·1, P,0·01), and after 21 days it reached 1·82 0·18 Hz, n=40 as compared with 1·21 0·11 Hz, n=54 (F(5,6)=7·92, P,0·001, Tukey's test, q=4·9, P,0·01).
Since the increase in 5-HT neuron firing activity, measured following progesterone treatments, was not present as expected from the results obtained during pregnancy , the possible implication of different progesterone metabolites was investigated. First, females were treated for 7, 14 and 21 days with 5 -DHP. The 7 day treatment led to a significant increase in 5-HT neuron basal firing rate (1·64 0·11 Hz, n=45 (F(5,6)=7·01, P,0·001, Tukey's test, q=6·0, P,0·01), Fig. 6 ). This was followed by a gradual decrease towards control values (Fig. 6) ; after 14 days of administration, the increase in firing rate was still statistically significant as compared with its control (1·57 0·09 Hz, n=78, vs 1·10 0·08 Hz, n=63, (F(5,6)=7·01, P,0·001, Tukey's test, q=5·2, P,0·01)) but not after 21 days of treatment (1·16 0·13 Hz, n=55, vs 1·22 0·11 Hz, n=46 (F(5,6)=7·01, P,0·001, Tukey's test, q=0·6, n.s.)).
The enzymes converting 5 -DHP into its metabolites 3 ,5 -THP and 3 ,5 -THP are present in the brain (Celotti et al. 1992 , Guennoun et al. 1995 . Therefore, FC were administered for 7 days with these metabolites but neither treatment led to a statistically significant increase in the firing rate of 5-HT neurons as compared with controls (3 ,5 -THP: 1·47 0·14 Hz, n=50 vs 1·23 0·13 Hz, n=47 (F(1,2)=1·52, n.s.) and 3 ,5 -THP: 1·51 0·12 Hz, n=68 vs 1·23 0·13 Hz, n=47 (F(1,2)=2·39, n.s.), Fig. 7) .
The effect of the other progesterone metabolite stereoisomers was also investigated. FC received a 7 day administration of 5 -DHP, 3 ,5 -THP and 3 ,5 -THP ( Fig. 8) . Neither 5 -DHP nor its metabolite 3 ,5 -THP significantly modified the firing activity of 5-HT neurons (1·12 0·09 Hz, n=63 (F(1,2)=0·33, n.s.) and 1·35 0·11 Hz, n=75 (F(1,2)=0·80, n.s.) respectively as compared with 1·20 0·10 Hz, n=42 for the controls). However, 3 ,5 -THP induced a pronounced increase in their firing rate (1·97 0·13 Hz, n=58 compared with 1·20 0·10 Hz, n=42 (F(1,2)=18·23, P,0·001)).
DHEA has been shown to have agonistic properties at receptors in a model using the N-methyl--aspartate response in the hippocampus . For this reason, FC were treated simultaneously with DHEA and the selective 1 antagonist NE-100 to investigate if the higher firing rate induced by DHEA was mediated by 1 receptors. NE-100, at a dose shown to block the effect of other ligands (Bermack & Debonnel 2001) , prevented the increase in firing rate induced by DHEA (controls: 0·96 0·08 Hz, n=52; DHEA: 1·48 0·11 Hz, n=78 (F(2,3)=6·22, P,0·005, Tukey's test, q=5·0, P,0·05); DHEA+NE-100: 1·22 0·10 Hz, n=70 (F(2,3)=6·22, P,0·005, Tukey's test, q=2·5, n.s.), Fig. 9 ) indicating that this effect was mediated by 1 receptors. Because the effect of 5 -DHP had a different time-frame, as compared with that of DHEA, the implication of 1 receptors was also investigated for this steroid. However, NE-100 did not prevent the 5 -DHP-induced increase in firing rate (controls: 1·06 0·07 Hz, n=86; 5 -DHP: 1·64 0·11 Hz, n=45 (F(2,3)=14·95, P,0·001, Tukey's test, q=6·4, P,0·05); 5 -DHP+NE-100: 1·67 0·14 Hz, n=40 (F(2,3)=6·23, P,0·001, Tukey's test, q=6·2, P,0·05), Fig. 10 ).
Discussion
The main findings of this study are (i) the increase in the firing activity of female 5-HT neurons following the chronic administration of some neuroactive steroids, i.e. 5 -DHP, 3 ,5 -THP and DHEA (Table 1 ) and (ii) the effect of DHEA but not of 5 -DHP is mediated, at least in part, by 1 receptors. Furthermore, the larger effects of some metabolites compared with those of progesterone, and the fact that progesterone is rapidly metabolized in the brain, suggests that the metabolites may play an important role in the modulation of the 5-HT neuronal activity.
In a previous study, we have shown that during pregnancy the spontaneous firing rate of 5-HT neurons is more than doubled . Moreover, the firing activity of 5-HT neurons changes in parallel with the plasma levels of progesterone . Our hypothesis was therefore that progesterone could be responsible for increasing the 5-HT neuronal activity in females. However, in OVX rats, the plasma levels of progesterone are much lower than in FC, while the firing rate of DRN 5-HT neurons is unchanged when compared with FC . This was suggesting that the de novo synthesis of progesterone, which is known to occur in the brain (Guennoun et al. 1995) , might be sufficient to maintain a normal level of the 5-HT neuron firing activity following OVX.
In rats treated with progesterone for 7 days, the absence of significant modification of the firing activity indicates that progesterone is probably not directly involved in the increase of 5-HT neuronal firing activity observed during pregnancy. Based on the literature, cerebral concentrations were extrapolated to be about four times higher than that reached by progesterone during pregnancy (Corpéchot et al. 1993) and are thus in the high physiological range. However, progesterone was administered only for 7 days and an effect of progesterone following a longer treatment cannot be ruled out.
Surprisingly, blocking cerebral progesterone synthesis in OVX rats, with a trilostane treatment, did not decrease the firing activity of the 5-HT neurons and there was even a trend towards an increase. Using different in vivo paradigms, similar or lower doses of trilostane were shown to efficiently inhibit the enzyme 3 -hydroxysteroid dehydrogenase (Potts et al. 1978 , Young et al. 1994 , Phan et al. 1999 , Micevych et al. 2003 . A possible explanation was thus that the blockade of progesterone synthesis could lead to a shift of the biosynthesis equilibrium towards a greater synthesis of DHEA (see Fig. 1 ). Rats were therefore treated with the precursor PREG as well as with DHEA. Administration of DHEA, but not of PREG, resulted in an enhanced firing activity of the DRN 5-HT neurons, which is in keeping with our hypothesis. Moreover, this DHEA-induced increase in 5-HT neuronal firing rate might explain the antidepressant effect observed with DHEA in humans (Wolkowitz et al. 1997) .
Another way to assess the possible effect of the local progesterone de novo synthesis was to block its catabolism, therefore increasing progesterone cerebral levels in OVX rats. Finasteride, a selective 5 -reductase inhibitor, was used for this purpose. It has previously been shown that the systemic administration of similar doses of finasteride efficiently blocks the enzymatic activity of cerebral 5 -reductase (Phan et al. 1999) . However, in our hands, this treatment did not significantly change the 5-HT neuron basal firing rate. This constitutes another indication that, contrary to our previous hypothesis, progesterone by itself is not involved directly in the control of the firing activity of DRN 5-HT neurons. This is also in keeping with the demonstration that following OVX, despite local progesterone synthesis, the cerebral content of progesterone was decreased by more than 70% (Corpéchot et al. 1993) but that there was no change in the firing activity of 5-HT neurons. Therefore, it appears that neurosteroids, other than progesterone, are involved in the modification of the firing activity of DRN 5-HT neurons observed during pregnancy.
Progesterone can be metabolized into 5 -DHP and 5 -DHP by the 5 -and 5 -reductase respectively, and then further reduced into 3 ,5 -THP and 3 ,5 -THP by the enzyme 3 -hydroxysteroid oxidoreductase (3 -HSOD) (Kawahara et al. 1975 , Karavolas & Hodges 1991 , Celotti et al. 1992 , Compagnone & Mellon 2000 . These three enzymes (5 -and 5 -reductases, and 3 -HSOD) are present, and active, in the mammalian brain (Kawahara et al. 1975 , 1981 , Celotti et al. 1992 ). It appears that the principal metabolic pathway for cerebral progesterone is its reduction into 5 -DHP and 3 ,5 -THP (Karavolas & Hodges 1991 , Korneyev et al. 1993 ) (see Fig. 1 ). Interestingly, 3 ,5 -THP was the most potent steroid of the present study. Since this steroid is probably the principal metabolite of progesterone, its levels may be elevated enough during pregnancy to substantially contribute to the increase in the firing activity of 5-HT neurons observed in pregnant rats.
A rather unexpected finding of this study was the different time-frame for the increase in firing activity of the 5-HT neurons caused by 5 -DHP and DHEA. The 5 -DHP-induced increase in firing activity was maximal after a 7 day treatment, followed by a gradual decline to finally lose statistical significance after 21 days of administration. On the other hand, the enhancement of the firing rate caused by DHEA was sustained over the 21 day period of time. This would support the hypothesis that more than one receptor is implicated in the effects seen with the different steroids tested in this study. Indeed, the DHEA-induced enhancement of the firing activity of 5-HT neurons seems to be mediated, at least in part, by 1 receptors, as shown by the fact that co-administration of the 1 receptor antagonist NE-100 prevented this effect. Interestingly, other ligands have been shown to increase the firing rate of 5-HT neurons in similar period of times and this effect could be blocked by NE-100 (Bermack & Debonnel 2001 , 2004 . Furthermore, the present results could suggest a physiological basis to the antidepressantlike effects observed for some neuroactive steroids in an animal model of depression, which effects were also shown to be mediated by 1 receptors (Reddy et al. 1998 , Urani et al. 2001 . On the other hand, NE-100 did not prevent the effect of 5 -DHP, thus indicating that other receptor(s) must mediate it. Also, the time-frame for the 5 -DHP-induced increase in firing activity could suggest a functional desensitization of the receptor mediating the effect of 5 -DHP on 5-HT neurons, whereas in the case of DHEA, there is no such indication, which is also in agreement with what is found with other ligands (Bermack & Debonnel 2001) .
The mechanism(s) by which progesterone metabolites increase the firing activity of 5-HT neurons is still unclear. However, based on our previous studies with pregnant rats, a partial desensitization of 5-HT 1A autoreceptors appears as a likely component . If neurosteroids, whose levels rise dramatically during pregnancy, are indeed responsible for the pregnancy-induced desensitization of 5-HT 1A autoreceptors, the intracerebral administration of neuroactive steroids could also lead to such desensitization. Since 5-HT 1A autoreceptors are inhibitory, their partial desensitization would easily explain the enhanced firing activity of 5-HT neurons reported in the present study.
On the other hand, recent studies have shown that DHEA promotes neurogenesis in the hippocampal dentate gyrus and protects it from glucocorticoids' detrimental effects (Karishma & Herbert 2002) . Interestingly, Santarelli et al. (2003) showed that inhibition of hippocampal neurogenesis prevents the behavioral effects of antidepressants in different animal models of depression. Together, these data offer another mechanism of action for the antidepressant effect of DHEA (Kaminska et al. 2000) . Further studies assessing the effect of other steroids on neurogenesis would be needed to assess whether this mechanism of action is specific to DHEA or if it might extend to other neurosteroids.
The effect of neuroactive steroids on 5-HT neurons activity could also be mediated through their interaction with GABA A receptors. It is well-known that 3 -reduced steroids are GABA A receptor modulators and can even act as proper agonists (Harrison et al. 1987 , Morrow et al. 1989 , Puia et al. 1990 , McCauley et al. 1995 . Progesterone, 5 -and 5 -DHP, devoid of such properties, are, however, rapidly converted into 3 ,5 -and 3 ,5 -THP, which can act on GABA A receptors (Bitran et al. 1993 , Lancel et al. 1996 . In rats, GABAergic neurons exert a tonic inhibition of DRN 5-HT neurons which seems to be mediated mostly by GABA A receptors (Innis & Aghajanian 1987 , Smith & Gallager 1987 , Gervasoni et al. 2000 . Interestingly, during pregnancy, the GABAergic tonic inhibition of the 5-HT neurons was dramatically reduced when compared with that of FC . Also, accumulating evidence suggests that sustained high levels of neuroactive steroids reduce GABA A receptor responsiveness and the efficacy of modulators to potentiate the chloride influx (Friedman et al. 1993 , Yu & Ticku 1995a ,b, Yu et al. 1996 , Concas et al. 1998 , Gulinello et al. 2001 . It is thus possible that sustained neurosteroids administration could cause both a desensitization of GABA A receptors and/or a diminution of the tonic GABAergic inhibition on 5-HT neurons and thus increase the firing activity of these neurons. Interestingly, 3 ,5 -THP has the most potent agonistic properties on GABA A receptors and induced the greatest increase in 5-HT neuron firing activity, whereas progesterone and 5 -DHP were devoid of significant effect, which is in keeping with this hypothesis.
The CSF and plasma of depressed patients have been shown to contain lower levels of 3 ,5 -THP and 3 ,5 -THP than those of healthy volunteers, which could be brought back up to normal levels by successful antidepressant treatments (Romeo et al. 1998 , Uzunova et al. 1998 , Ströhle et al. 1999 . No differences in progesterone levels were observed (Romeo et al. 1998 , Uzunova et al. 1998 . Lower serum levels of 3 ,5 -THP were observed both in women suffering from premenstrual syndrome, during the luteal phase of their menstrual cycle, and in women with postpartum blues as compared with corresponding controls (Rapkin et al. 1997 , Nappi et al. 2001 . It was suggested that fluoxetine and other SSRIs interact with the enzyme 3 -HSD, responsible for the reversible conversion of 5 -and 5 -DHP into their respective 3 -reduced metabolites (3 , . This interaction would favor the reduction reaction and would reduce the rate of the oxidative reaction (i.e. conversion of 3 ,5 -and 3 ,5 -THP into 5 -and 5 -DHP), thus leading to enhanced levels of 3 ,5 -and 3 ,5 -THP (Uzunov et al. 1996 , Uzunova et al. 1998 , Griffin & Mellon 1999 .
Together, these studies could suggest an association between depressive states with a decrease in 3 ,5 -THP levels, and mood improvement with an enhancement of the steroid levels. In agreement with this hypothesis, our results show that 3 ,5 -THP significantly increases the 5-HT neuron firing activity in females. Since all antidepressant treatments increase the efficacy of the 5-HT neurotransmission, these results could suggest a potential antidepressant effect for some neuroactive steroids.
Even if a clear link has not yet been firmly established, recent reports have suggested that hormonal replacement therapy (HRT) could induce undesirable side effects (see review by Armitage et al. 2003) , which has led many patients to stop their HRT treatments. Natural hormones might, therefore, not be the best candidates as long-term adjuvants for antidepressant treatments, which would have to be administered presumably for several years to patients suffering from refractory depression. However, synthetic compounds having a similar pharmacological profile and the same effects on 5-HT neurons, which could be administered systemically, become interesting candidates. Therefore, the modulation by neurosteroids of the firing activity of 5-HT neurons, reported here, may prove important for the treatment of female mood disorders.
